Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus.
將此醫學文章的標題翻譯為繁體中文(zh-TW)：「empagliflozin 和 sitagliptin 作為 metformin 輔助治療對第二型糖尿病患者血清 asprosin 水平和代謝參數的影響比較」。
Naunyn Schmiedebergs Arch Pharmacol 2024-06-20
Slope of change in HbA<sub>1c</sub> from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes.
Empagliflozin 與 Sitagliptin 或 Glimepiride 相比，在 2 型糖尿病患者中，HbA<sub>1c</sub> 從基線變化的斜率。
Endocrinol Diabetes Metab 2023-10-05
Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients.
第二型糖尿病患者使用二甲双胍後，Empagliflozin與Sitagliptin的療效隨機臨床試驗。
Cureus 2022-12-24
Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitus.
二型糖尿病患者達帕格列酮和恩帕格列酮臨床結果的比較評估。
Ir J Med Sci 2023-09-28
Assessment of empagliflozin add-on therapy to metformin and glimepiride in patients with inadequately controlled type-2 diabetes mellitus.
評估 empagliflozin 作為附加治療加入二甲双胍和格列美脲，治療控制不佳的2型糖尿病患者。
Pak J Pharm Sci 2023-03-03
Long-Term Effectiveness of Quadruple Combination Therapy with Empagliflozin Versus Basal Long-Acting Insulin Therapy in Patients with Type 2 Diabetes: 3-Year Retrospective Observational Study.
二型糖尿病患者三年回顧性觀察研究：Empagliflozin 四合一組合療法與基礎長效胰島素治療的長期效果。
Diabetes Ther 2023-08-01
Adding empagliflozin to sitagliptin plus metformin vs. adding sitagliptin to empagliflozin plus metformin as triple therapy in Egyptian patients with type 2 diabetes: a 12-week open trial.
將 empagliflozin 加入 sitagliptin 與 metformin vs. 將 sitagliptin 加入 empagliflozin 與 metformin 作為三重療法治療埃及第二型糖尿病患者：一項為期 12 週的開放性試驗。
Eur Rev Med Pharmacol Sci 2023-10-19
A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation.
將此醫學文章的標題翻譯為繁體中文：「Empagliflozin 和 Sitagliptin 聯合二甲双胍治療對第二型糖尿病患者血脂水平影響之比較：臨床研究」。
Cureus 2023-10-31
Comparative Study on Efficacy of Empagliflozin Versus Sitagliptin, as an Add-on Therapy to Metformin in Type 2 Diabetic Patients.
二型糖尿病患者甲狀腺素與西格列汀作為二甲双胍輔助治療的療效比較研究。
J Pharm Bioallied Sci 2024-04-11
Evaluating the efficacy and safety of empagliflozin addition to insulin and oral antidiabetic medication (OAD) regimen in poorly controlled type 2 diabetes and obese patients.
評估將 empagliflozin 添加至胰島素和口服抗糖尿病藥物（OAD）方案中，對控制不佳的2型糖尿病和肥胖患者的療效和安全性。
Pak J Pharm Sci 2024-05-20